Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroOne Medical Tech Q3 EPS $(0.20), Inline, Sales $629.91K Beat $350.00K Estimate

Author: Benzinga Newsdesk | August 14, 2023 04:24pm
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 17.65 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $629.91 thousand which beat the analyst consensus estimate of $350.00 thousand by 79.97 percent. This is a 1.87K percent increase over sales of $32.05 thousand the same period last year.

Posted In: NMTC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist